Crispr Therapeutics shares owned by Arete Wealth Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Arete Wealth Advisors
from 13F filings
Historical chart of Arete Wealth Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Arete Wealth Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Arete Wealth Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $743k | 11k | 68.16 |
| 2023-12-31 | $689k | 11k | 62.60 |
| 2023-09-30 | $527k | 12k | 45.39 |
| 2023-06-30 | $602k | 11k | 56.10 |
| 2023-03-31 | $498k | 11k | 45.22 |
| 2022-12-31 | $230M | 5.7k | 40650.00 |
| 2022-09-30 | $511k | 7.8k | 65.34 |
| 2022-06-30 | $405k | 6.7k | 60.74 |
| 2021-09-30 | $277k | 2.5k | 110.53 |
| 2021-06-30 | $303k | 2.5k | 123.57 |
| 2020-12-31 | $250k | 1.6k | 156.45 |